You know this trial is a double-blinded control trial right? The data doesn't get unlocked prior to complete patient enrolment and after the last time-point. This extension is not a reflection of "quality data" being seen. This (as they stated), is due to feedback from KOL's that twice weekly injections isn;t commercially appetising, hence they're trying once a week. IMO
Ann: Phase 2 Synovial Fluid Biomarker Study Update, page-49
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $96.19M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 27.5¢ | 27.5¢ | $3.764K | 13.68K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 56176 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 16499 | 2 |
View Market Depth
| Last trade - 10.08am 11/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |